Nagraj Mani

2.1k total citations
36 papers, 1.3k citations indexed

About

Nagraj Mani is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Nagraj Mani has authored 36 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Epidemiology, 17 papers in Hepatology and 13 papers in Infectious Diseases. Recurrent topics in Nagraj Mani's work include Hepatitis C virus research (17 papers), Hepatitis B Virus Studies (16 papers) and Bacterial Genetics and Biotechnology (8 papers). Nagraj Mani is often cited by papers focused on Hepatitis C virus research (17 papers), Hepatitis B Virus Studies (16 papers) and Bacterial Genetics and Biotechnology (8 papers). Nagraj Mani collaborates with scholars based in United States, France and Belgium. Nagraj Mani's co-authors include Bruno Dupuy, Radheshyam K. Jayaswal, Trudy H. Grossman, Abraham L. Sonenshein, Steve Mullin, Philip J. Tobin, Michiko Nakano, Cécile Jourlin‐Castelli, Paul S. Charifson and Dean Stamos and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Molecular Biology and Journal of Virology.

In The Last Decade

Nagraj Mani

36 papers receiving 1.2k citations

Peers

Countries citing papers authored by Nagraj Mani

Since Specialization

Citations

This map shows the geographic impact of Nagraj Mani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nagraj Mani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nagraj Mani more than expected).

Fields of papers citing papers by Nagraj Mani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nagraj Mani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nagraj Mani. The network helps show where Nagraj Mani may publish in the future.

Co-authorship network of co-authors of Nagraj Mani

This figure shows the co-authorship network connecting the top 25 collaborators of Nagraj Mani. A scholar is included among the top collaborators of Nagraj Mani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nagraj Mani. Nagraj Mani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Conformationally Constrained Isoquinolinones as Orally Efficacious Hepatitis B Capsid Assembly Modulators 2024 ·ACS Medicinal Chemistry Letters ·Eugen F. Mesaros, Andrew G. Cole, Steven G. Kultgen, Nagraj Mani, Kristi Fan, (unknown), (unknown), (unknown), Holly M. Micolochick Steuer, (unknown), (unknown), Troy O. Harasym, Angela M. Lam, Emily P. Thi, Bruce D. Dorsey, Michael J. Sofia	2
2	Rational Design, Synthesis, and Structure–Activity Relationship of a Novel Isoquinolinone-Based Series of HBV Capsid Assembly Modulators Leading to the Identification of Clinical Candidate AB-836 2024 ·Journal of Medicinal Chemistry ·Andrew G. Cole, Steven G. Kultgen, Nagraj Mani, Kristi Fan, (unknown), (unknown), Bruce D. Dorsey, Eugen F. Mesaros, Emily P. Thi, (unknown), (unknown), Troy O. Harasym, Amy C. H. Lee, Andrea Olland, R.K. Suto, Michael J. Sofia	4
3	Design, synthesis, and structure-activity relationship of a bicyclic HBV capsid assembly modulator chemotype leading to the identification of clinical candidate AB-506 2023 ·Bioorganic & Medicinal Chemistry Letters ·Andrew G. Cole, Steven G. Kultgen, Nagraj Mani, (unknown), Kristi Fan, (unknown), (unknown), Bruce D. Dorsey, Janet R. Phelps, Amy C. H. Lee, Emily P. Thi, Tim Chiu, (unknown), P.S. Horanyi, Stephen J. Mayclin, Troy O. Harasym, Michael J. Sofia	4
4	Safety, pharmacokinetics, and antiviral activity of the capsid inhibitor AB‐506 from Phase 1 studies in healthy subjects and those with hepatitis B 2022 ·Hepatology Communications ·Man‐Fung Yuen, Elina Berliba, Wattana Sukeepaisarnjaroen, Sang Hoon Ahn, Tawesak Tanwandee, Young‐Suk Lim, Yoon Jun Kim, Kittiyod Poovorawan, Pisit Tangkijvanich, Christian Schwabe, Timothy Eley, J. B. Brown, Amy C. H. Lee, Emily P. Thi, Bhavna Paratala, Nagraj Mani, Michael J. Sofia, Gastón Picchio, Karen Sims, Edward Gane	17
5	Nomenclature of HBV core protein-targeting antivirals 2022 ·Nature Reviews Gastroenterology & Hepatology ·Fabien Zoulim, Adam Zlotnick, Stephanie Buchholz, Eric Donaldson, John Fry, Anuj Gaggar, Jianming Hu, Michael Kann, Oliver Lenz, Kai Lin, Nagraj Mani, Michael Nassal, William E. Delaney, Su Wang, Gabriel Westman, Veronica Miller, Harry L.A. Janssen	40
6	Targeting the multifunctional HBV core protein as a potential cure for chronic hepatitis B 2020 ·Antiviral Research ·(unknown), Nagraj Mani, Zhanying Hu, (unknown), Yanming Du, Jin Hu, Jinhong Chang, Ju‐Tao Guo	75
7	Inhibition of HBV replication by N-hydroxyisoquinolinedione and N-hydroxypyridinedione ribonuclease H inhibitors 2019 ·Antiviral Research ·(unknown), Nagraj Mani, Bruce D. Dorsey, (unknown), René Rijnbrand, Michael J. Sofia, John E. Tavis	30
8	Successful application of serum shift prediction models to the design of dual targeting inhibitors of bacterial gyrase B and topoisomerase IV with improved in vivo efficacy 2014 ·Bioorganic & Medicinal Chemistry Letters ·Emanuele Perola, Dean Stamos, Anne‐Laure Grillot, (unknown), Tiansheng Wang, Arnaud LeTiran, Qing Tang, David D. Deininger, Yusheng Liao, Shi‐Kai Tian, Joseph E. Drumm, David P. Nicolau, Pamela R. Tessier, Nagraj Mani, Trudy H. Grossman, Paul S. Charifson	8
9	In Vitro Phenotypic Characterization of Hepatitis C Virus NS3 Protease Variants Observed in Clinical Studies of Telaprevir 2013 ·Antimicrobial Agents and Chemotherapy ·Min Jiang, Nagraj Mani, Chao Lin, (unknown), Michelle Nelson, (unknown), Doug J. Bartels, Yi Zhou, Olivier Nicolas, B. Govinda Rao, Ute Müh, Brian L. Hanzelka, Ann M. Tigges, René Rijnbrand, Tara L. Kieffer	25
10	Discovery of pyrazolthiazoles as novel and potent inhibitors of bacterial gyrase 2010 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Michael C. Badia, S.F. Bellon, Anne‐Laure Grillot, Christian H. Gross, Trudy H. Grossman, Nagraj Mani, Jonathan D. Parsons, Dean Stamos, Martin Trudeau, Yunyi Wei, Paul S. Charifson	85
11	Regulation of toxin and bacteriocin gene expression in Clostridium by interchangeable RNA polymerase sigma factors 2006 ·Molecular Microbiology ·Bruno Dupuy, Stéphanie Raffestin, Susana Matamouros, Nagraj Mani, Michel R. Popoff, Abraham L. Sonenshein	45
12	Transcription activation of a UV‐inducible Clostridium perfringens bacteriocin gene by a novel σ factor 2005 ·Molecular Microbiology ·Bruno Dupuy, Nagraj Mani, Seiichi Katayama, Abraham L. Sonenshein	26
13	Isolation of RNA Polymerase from Clostridium difficile and Characterization of Glutamate Dehydrogenase and rRNA Gene Promoters In Vitro and In Vivo 2005 ·Journal of Bacteriology ·Nagraj Mani, Bruno Dupuy, Abraham L. Sonenshein	9
14	A Pathway-specific Cell Based Screening System to Detect Bacterial Cell Wall Inhibitors. 2002 ·The Journal of Antibiotics ·Dongyu Sun, (unknown), Nagraj Mani, Christopher R. Murphy, David M. Rothstein	33
15	Environmental Response and Autoregulation of Clostridium difficile TxeR, a Sigma Factor for Toxin Gene Expression 2002 ·Journal of Bacteriology ·Nagraj Mani, Dena Lyras, Lisa Barroso, Pauline M. Howarth, Tracy D. Wilkins, Julian I. Rood, Abraham L. Sonenshein, Bruno Dupuy	96
16	CcpC, a novel regulator of the LysR family required for glucose repression of the citB gene in Bacillus subtilis 2000 ·Journal of Molecular Biology ·Cécile Jourlin‐Castelli, Nagraj Mani, Michiko Nakano, Abraham L. Sonenshein	85
17	Screening Systems for Detecting Inhibitors of Cell Wall Transglycosylation in Enterococcus.Cell Wall Transglycosylation Inhibitors in Enterococcus. 1998 ·The Journal of Antibiotics ·Nagraj Mani, (unknown), Zhi‐Dong Jiang, (unknown), Maureen T. DeCenzo, (unknown), (unknown), Mike Kuranda, David M. Rothstein	30
18	Molecular analysis of lytic genes of bacteriophage 80α ofStaphylococcus aureus 1997 ·Canadian Journal of Microbiology ·(unknown), Nagraj Mani, Radheshyam K. Jayaswal	13
19	Effect of physiological conditions on the autolysis ofStaphylococcus aureus strains 1994 ·Antonie van Leeuwenhoek ·Philip J. Tobin, Nagraj Mani, Radheshyam K. Jayaswal	16
20	Study of 90 hepatitis B surface antigen carriers in Israel. 1981 ·PubMed ·Daniel Shouval, R Tur-Kaspa, Ruth Adler, Nagraj Mani, S Penchas, M Roggendorf, (unknown), M Eliakim	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact